$15.56
0[0.00%]
At close: Apr 24
$15.56
0[0.00%]
PreMarket: 4:20PM EDT
Denali Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Denali Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | DNLI | Q1 | -$0.80 | -$0.71 | — | — | $35.14M | $14.15M | — | — | Get Alert |
02/27/2024 | AM | DNLI | Q4 | -$0.75 | -$0.80 | -$0.86 | -7.50% | $10.28M | $8.36M | $0.00 | -100.00% | Get Alert |
11/07/2023 | PM | DNLI | Q3 | -$0.84 | -$0.82 | -$0.72 | 12.20% | $3.56M | $10.80M | $1.27M | -88.27% | Get Alert |
08/08/2023 | PM | DNLI | Q2 | -$0.48 | -$0.68 | $1.30 | 291.18% | $52.48M | $13.46M | $294.12M | 2085.16% | Get Alert |
05/08/2023 | PM | DNLI | Q1 | -$0.53 | -$0.70 | -$0.80 | -14.29% | $42.14M | $28.72M | $35.14M | 22.36% | Get Alert |
02/27/2023 | PM | DNLI | Q4 | -$0.62 | -$0.79 | -$0.75 | 5.06% | $12.50M | $13.12M | $10.28M | -21.62% | Get Alert |
11/03/2022 | PM | DNLI | Q3 | -$0.69 | -$0.81 | -$0.84 | -3.70% | $5.29M | $14.47M | $3.56M | -75.40% | Get Alert |
08/08/2022 | PM | DNLI | Q2 | -$0.50 | -$0.55 | -$0.48 | 12.73% | $22.94M | $43.90M | $52.48M | 19.54% | Get Alert |
05/05/2022 | AM | DNLI | Q1 | -$0.58 | -$0.51 | -$0.53 | -3.92% | $7.92M | $25.69M | $42.14M | 64.04% | Get Alert |
02/28/2022 | PM | DNLI | Q4 | $1.91 | — | -$0.62 | — | $316.81M | — | $12.51M | — | Get Alert |
11/04/2021 | PM | DNLI | Q3 | -$0.54 | -$0.47 | -$0.69 | -46.81% | $9.39M | $30.28M | $5.29M | -82.55% | Get Alert |
08/04/2021 | PM | DNLI | Q2 | -$0.56 | -$0.40 | -$0.50 | -25.00% | $5.85M | $29.35M | $22.94M | -21.84% | Get Alert |
05/03/2021 | AM | DNLI | Q1 | -$0.55 | — | -$0.58 | — | $3.60M | — | $7.92M | — | Get Alert |
02/25/2021 | PM | DNLI | Q4 | -$0.56 | — | $1.91 | — | $4.67M | — | $316.81M | — | Get Alert |
11/05/2020 | PM | DNLI | Q3 | -$0.48 | — | -$0.54 | — | $13.60M | — | $9.39M | — | Get Alert |
08/07/2020 | PM | DNLI | Q2 | -$0.61 | — | -$0.56 | — | $4.20M | — | $5.85M | — | Get Alert |
05/07/2020 | PM | DNLI | Q1 | -$0.41 | — | -$0.55 | — | $4.21M | — | $3.60M | — | Get Alert |
02/27/2020 | PM | DNLI | Q4 | $0.79 | — | -$0.56 | — | $125.68M | — | $4.67M | — | Get Alert |
11/06/2019 | PM | DNLI | Q3 | -$0.38 | — | -$0.48 | — | $1.20M | — | $13.60M | — | Get Alert |
Denali Therapeutics (DNLI) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $-0.86, which missed the estimate of $-0.80.
The Actual Revenue was $0K, which missed the estimate of $8.4M.
Browse earnings estimates, EPS, and revenue on all stocks.